These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18227109

  • 1. Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management.
    Penack O, Rempf P, Graf B, Blau IW, Thiel E.
    Ann Oncol; 2008 May; 19(5):984-9. PubMed ID: 18227109
    [Abstract] [Full Text] [Related]

  • 2. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.
    Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S.
    Br J Haematol; 2003 May; 121(3):448-57. PubMed ID: 12716367
    [Abstract] [Full Text] [Related]

  • 3. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.
    Heng SC, Morrissey O, Chen SC, Thursky K, Manser RL, Nation RL, Kong DC, Slavin M.
    Crit Rev Microbiol; 2015 Feb; 41(1):124-34. PubMed ID: 23799871
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I, Makni F, Cheikhrouhou F, Neji S, Amouri I, Sellami H, Trabelsi H, Bellaaj H, Elloumi M, Ayadi A.
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [Abstract] [Full Text] [Related]

  • 5. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
    Ulusakarya A, Chachaty E, Vantelon JM, Youssef A, Tancrède C, Pico JL, Bourhis JH, Fenaux P, Munck JN.
    Hematol J; 2000 Dec; 1(2):111-6. PubMed ID: 11920178
    [Abstract] [Full Text] [Related]

  • 6. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, Khoo KL, Tambyah PA.
    BMC Infect Dis; 2010 Mar 03; 10():44. PubMed ID: 20199673
    [Abstract] [Full Text] [Related]

  • 7. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA.
    J Clin Microbiol; 2004 Dec 03; 42(12):5517-22. PubMed ID: 15583275
    [Abstract] [Full Text] [Related]

  • 8. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
    Paholcsek M, Fidler G, Konya J, Rejto L, Mehes G, Bukta E, Loeffler J, Biro S.
    BMC Infect Dis; 2015 Jul 01; 15():251. PubMed ID: 26126706
    [Abstract] [Full Text] [Related]

  • 9. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z, Kocmanova I, Toskova M, Buresova L, Weinbergerova B, Lengerova M, Rolencova M, Winterova J, Hrncirova K, Volfova P, Skrickova J, Mayer J.
    Int J Infect Dis; 2011 Dec 01; 15(12):e874-81. PubMed ID: 22040924
    [Abstract] [Full Text] [Related]

  • 10. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T, Neuenhahn M, Held J, Rasch S, Schmid RM, Huber W.
    J Crit Care; 2016 Dec 01; 36():259-264. PubMed ID: 27475024
    [Abstract] [Full Text] [Related]

  • 11. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S, Hoenigl M, Spiess B, Heldt S, Prattes J, Neumeister P, Wolfler A, Rabensteiner J, Prueller F, Krause R, Reinwald M, Flick H, Buchheidt D, Boch T.
    Med Mycol; 2017 Jul 01; 55(5):528-534. PubMed ID: 27744310
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S, Kuştimur S, Kalkancı A.
    Mikrobiyol Bul; 2010 Jul 01; 44(3):441-52. PubMed ID: 21063994
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O, Saba R, Akalin EH, Ener B, Ture Yuce Z, Deveci B, Guncu MM, Kahveci HN, Yilmaz AF, Odabasi Z.
    Mycopathologia; 2023 Oct 01; 188(5):643-653. PubMed ID: 37273172
    [Abstract] [Full Text] [Related]

  • 14. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
    Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E.
    Am J Respir Crit Care Med; 2008 Jan 01; 177(1):27-34. PubMed ID: 17885264
    [Abstract] [Full Text] [Related]

  • 15. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V, Wheat LJ, Wingard JR.
    Biol Blood Marrow Transplant; 2011 Jul 01; 17(7):1043-50. PubMed ID: 21087680
    [Abstract] [Full Text] [Related]

  • 16. The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.
    Oz Y, Aslan M, Aksit F, Metintas S, Gunduz E.
    Mycoses; 2016 Feb 01; 59(2):86-92. PubMed ID: 26627843
    [Abstract] [Full Text] [Related]

  • 17. [Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].
    Jarque I, Andreu R, Salavert M, Gómez D, Pemán J, Gobernado M, Sanz MA.
    Rev Iberoam Micol; 2003 Sep 01; 20(3):116-8. PubMed ID: 15456368
    [Abstract] [Full Text] [Related]

  • 18. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
    Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, Schaufele R, Hope WW, Shea YR, Bacher J, Walsh TJ.
    J Clin Microbiol; 2006 Jul 01; 44(7):2475-80. PubMed ID: 16825367
    [Abstract] [Full Text] [Related]

  • 19. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P, Foongladda S, Tscheikuna J.
    J Med Assoc Thai; 2010 Jan 01; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [Abstract] [Full Text] [Related]

  • 20. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P, Daie-Ghazvini R, Hashemi SJ, Salehi MR, Bakhshi H, Rafat Z, Zareei M, Getso M, Basiri S, Sarwestani HK, Boroujeini ZB, Ahmadikia K.
    Microb Pathog; 2020 Oct 01; 147():104382. PubMed ID: 32663605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.